Development of genetic profiles-based nomograms for predicting survival among EGFR-mutant lung cancer.

Journal of Clinical Oncology(2018)

引用 0|浏览7
暂无评分
摘要
e21219Background: Not all advanced non-small-cell lung cancer (NSCLC) patients respond equally to tyrosine kinase inhibitor (TKI) treatments, despite the presence of sensitizing epidermal growth fa...
更多
查看译文
关键词
Lung cancer,Tyrosine-kinase inhibitor,Cancer research,Mutant,Nomogram,Medicine
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要